Cargando…

Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia

Juvenile myelomonocytic leukemia (JMML) treatment primarily relies on hematopoietic stem cell transplantation and results in long-term overall survival of 50–60%, demonstrating a need to develop novel treatments. Dysregulation of the non-coding RNA transcriptome has been demonstrated before in this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofmans, Mattias, Lammens, Tim, Depreter, Barbara, Wu, Ying, Erlacher, Miriam, Caye, Aurélie, Cavé, Hélène, Flotho, Christian, de Haas, Valerie, Niemeyer, Charlotte M., Stary, Jan, Van Nieuwerburgh, Filip, Deforce, Dieter, Van Loocke, Wouter, Van Vlierberghe, Pieter, Philippé, Jan, De Moerloose, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854679/ https://www.ncbi.nlm.nih.gov/pubmed/33531590 http://dx.doi.org/10.1038/s41598-021-82509-5

Ejemplares similares

CircRNAs Dysregulated in Juvenile Myelomonocytic Leukemia: CircMCTP1 Stands Out
por: Dal Molin, Anna, et al.
Publicado: (2021)

Current Treatment of Juvenile Myelomonocytic Leukemia
por: Mayerhofer, Christina, et al.
Publicado: (2021)

Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia
por: Ghazavi, Farzaneh, et al.
Publicado: (2016)

P1000: JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) INHIBITS T CELL PROLIFERATION VIA THE ECTONUCLEOTIDASE CD39 AND THE PURINERGIC NETWORK
por: Rajak, Jovana, et al.
Publicado: (2023)

Deciphering the Non-Coding RNA Landscape of Pediatric Acute Myeloid Leukemia
por: Vanhooren, Jolien, et al.
Publicado: (2022)

Clinical Significance of TARP Expression in Pediatric Acute Myeloid Leukemia
por: Depreter, Barbara, et al.
Publicado: (2020)

TARP as antigen in cancer immunotherapy
por: Vanhooren, Jolien, et al.
Publicado: (2021)

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
por: Lipka, Daniel B., et al.
Publicado: (2017)

Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
por: Niemeyer, Charlotte M., et al.
Publicado: (2010)

CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia
por: Fluhr, Silvia, et al.
Publicado: (2016)

Induced Pluripotent Stem Cells to Model Juvenile Myelomonocytic Leukemia: New Perspectives for Preclinical Research
por: Wehbe, Zeinab, et al.
Publicado: (2021)

S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT
por: Hartmann, Mark, et al.
Publicado: (2023)

Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy
por: Van Trimpont, Maaike, et al.
Publicado: (2022)

TXNIP Promotes Human NK Cell Development but Is Dispensable for NK Cell Functionality
por: Persyn, Eva, et al.
Publicado: (2022)

Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia
por: Stieglitz, Elliot, et al.
Publicado: (2017)

P468: DETECTION AND CHARACTERIZATION OF RESIDUAL LEUKEMIC CELLS IN CHILDHOOD ACUTE MYELOID LEUKEMIA USING TARGETED DEEP SEQUENCING AND SINGLE CELL MULTI-OMICS
por: Saeed, Borhan R, et al.
Publicado: (2023)

T-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells
por: Kiekens, Laura, et al.
Publicado: (2021)

IRF2 is required for development and functional maturation of human NK cells
por: Persyn, Eva, et al.
Publicado: (2022)

Comprehensive miRNA expression profiling in human T-cell acute lymphoblastic leukemia by small RNA-sequencing
por: Wallaert, Annelynn, et al.
Publicado: (2017)

Proteomic Analysis of an Induced Pluripotent Stem Cell Model Reveals Strategies to Treat Juvenile Myelomonocytic Leukemia
por: Pearson, Stella, et al.
Publicado: (2019)

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
por: Depreter, Barbara, et al.
Publicado: (2020)

The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency
por: Wahlen, Sigrid, et al.
Publicado: (2022)

The Genomic Landscape of Juvenile Myelomonocytic Leukemia
por: Stieglitz, Elliot, et al.
Publicado: (2015)

The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencing
por: Zubovic, Lorena, et al.
Publicado: (2020)

MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment
por: Leoncini, Pier Paolo, et al.
Publicado: (2016)

CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them
por: Vanhooren, Jolien, et al.
Publicado: (2023)

P816: TRANSIENT MONOSOMY 7 IN SAMD9/9L SYNDROMES: IS IT SAFE TO WATCH AND WAIT?
por: Erlacher, M., et al.
Publicado: (2022)

Molecular and phenotypic diversity of CBLmutated juvenile myelomonocytic leukemia
por: Hecht, Anna, et al.
Publicado: (2020)

Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
por: Liu, Xiaoling, et al.
Publicado: (2012)

Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia
por: Fiñana, Claudia, et al.
Publicado: (2022)

Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
por: Vinci, Luca, et al.
Publicado: (2023)

Suspension fluorescence in situ hybridization (S-FISH) combined with automatic detection and laser microdissection for STR profiling of male cells in male/female mixtures
por: Vandewoestyne, Mado, et al.
Publicado: (2009)

Diagnostic performance of the loop-mediated isothermal amplification (LAMP) based illumigene(®) malaria assay in a non-endemic region
por: De Koninck, Anne-Sophie, et al.
Publicado: (2017)

Novel splicing-factor mutations in juvenile myelomonocytic leukemia
por: Takita, J, et al.
Publicado: (2012)

P1072: NATURAL HISTORY OF JUVENILE MYELOMONOCYTIC LEUKEMIA
por: Yang, W., et al.
Publicado: (2022)

Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia
por: Louka, Eleni, et al.
Publicado: (2021)

Impact of allelic dropout on evidential value of forensic DNA profiles using RMNE
por: Van Nieuwerburgh, F., et al.
Publicado: (2009)

Metabolic activity, urease production, antibiotic resistance and virulence in dual species biofilms of Staphylococcus epidermidis and Staphylococcus aureus
por: Vandecandelaere, Ilse, et al.
Publicado: (2017)

Massively parallel sequencing of micro-manipulated cells targeting a comprehensive panel of disease-causing genes: A comparative evaluation of upstream whole-genome amplification methods
por: Deleye, Lieselot, et al.
Publicado: (2018)

Use of Rapamycin in a Patient With Juvenile Myelomonocytic Leukemia: A Case Report
por: Upadhyay, Shivani Y., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ks8nqmlcd4rikt5lhnqcqlpfcd